Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

NCT02960711 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Metformin Hydrochloride 850 MG Oral Tablet [Glucophage]
DRUG: Ludipress, mg stereate, micronized hydrated silica, talcum

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano